Pharm-Bio Serv Inc (PBSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2023 | 07-2023 | 04-2023 | 01-2023 | 10-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,446 | 2,870 | 8,097 | 7,225 | 14,463 |
| Marketable Securities | 4,531 | 11,715 | 5,504 | 8,248 | N/A |
| Receivables | 3,941 | 4,631 | 5,029 | 4,326 | 4,983 |
| TOTAL | $19,401 | $19,731 | $19,004 | $20,237 | $19,944 |
| Non-Current Assets | |||||
| PPE Net | 33 | 42 | 53 | 66 | 74 |
| Other Non-Current Assets | 468 | 524 | 561 | 598 | 634 |
| TOTAL | $501 | $566 | $614 | $664 | $707 |
| Total Assets | $19,902 | $20,297 | $19,618 | $20,900 | $20,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,467 | 1,680 | 1,536 | 1,329 | 1,630 |
| TOTAL | $2,154 | $2,450 | $2,245 | $1,962 | $2,108 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,622 | 1,661 | 1,699 | 1,949 | 1,986 |
| TOTAL | $1,622 | $1,661 | $1,699 | $1,949 | $1,986 |
| Total Liabilities | $3,775 | $4,111 | $3,944 | $3,910 | $4,093 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,963 | 22,963 | 22,966 | 22,967 | 22,950 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 14,854 | 14,901 | 14,375 | 15,694 | 15,268 |
| Other shareholders' equity | 674 | 686 | 716 | 728 | 736 |
| TOTAL | $16,127 | $16,186 | $15,674 | $16,990 | $16,558 |
| Total Liabilities And Equity | $19,902 | $20,297 | $19,618 | $20,900 | $20,651 |